NasdaqCM - Nasdaq Real Time Price USD

Cognition Therapeutics, Inc. (CGTX)

0.3011
-0.0289
(-8.76%)
At close: May 9 at 4:00:00 PM EDT
0.3901
+0.09
+(29.56%)
After hours: May 9 at 7:59:59 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
34,417
34,417
25,919
21,334
11,151
Operating Income
-34,417
-34,417
-25,919
-21,334
-11,151
Net Non Operating Interest Income Expense
-25
-25
-27
-28
-893
Other Income Expense
471
471
158
-35
328
Pretax Income
-33,971
-33,971
-25,788
-21,397
-11,716
Net Income Common Stockholders
-33,971
-33,971
-25,788
-21,397
-16,248
Diluted NI Available to Com Stockholders
-33,971
-33,971
-25,788
-21,397
-16,248
Basic EPS
-0.86
--
-0.86
-0.91
-3.13
Diluted EPS
-0.86
--
-0.86
-0.91
-3.13
Basic Average Shares
39,730.1480
--
30,029.0870
23,640.1990
5,190.8830
Diluted Average Shares
39,730.1480
--
30,029.0870
23,640.1990
5,190.8830
Total Operating Income as Reported
-53,966
-53,966
-50,724
-43,551
-28,598
Total Expenses
34,417
34,417
25,919
21,334
11,151
Net Income from Continuing & Discontinued Operation
-33,971
-33,971
-25,788
-21,397
-11,716
Normalized Income
-33,776
-33,776
-25,788
-21,397
-14,368
Interest Expense
25
25
27
28
893
Net Interest Income
-25
-25
-27
-28
-893
EBIT
-33,946
-33,946
-25,761
-21,369
-10,823
EBITDA
-33,680
-33,680
-25,509
-21,134
-10,730
Reconciled Depreciation
266
266
252
235
93
Net Income from Continuing Operation Net Minority Interest
-33,971
-33,971
-25,788
-21,397
-11,716
Total Unusual Items Excluding Goodwill
-195
-195
0
0
2,652
Total Unusual Items
-195
-195
0
0
2,652
Normalized EBITDA
-33,485
-33,485
-25,509
-21,134
-13,382
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 10/8/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ACTU Actuate Therapeutics, Inc. Common stock
10.35
+4.55%
 
AVXL Anavex Life Sciences Corp.
8.25
-3.62%
 
TNFA TNF Pharmaceuticals, Inc.
0.1900
-3.36%
 
ZVSA ZyVersa Therapeutics, Inc.
0.5272
-7.70%
 
IRD Opus Genetics, Inc.
0.9468
-4.92%
 
LPCN Lipocine Inc.
3.2750
-1.65%
 
ALZN Alzamend Neuro, Inc.
0.6581
+21.87%
 
INAB IN8bio, Inc.
0.1574
-6.25%
 
RNTX Rein Therapeutics Inc.
1.7600
+1.15%
 
TOVX Theriva Biologics, Inc.
0.5299
-17.61%